|
IT201900003843A1
|
|
Treatment of fibroids with vitamin D and an agent such as epigallocatechin gallate (EGCG)
|
|
IT201700104446A1
|
|
Compositions, uses and methods for the treatment of infertility and subfertility
|
|
EP3407891A1
|
|
Topical/local administration of inositol hexaphosphate as an adjuvant in anticancer treatments
|
|
WO2016113679A1
|
|
Lipoic acid for treating or preventing threatened miscarriage or preterm delivery
|
|
WO2014096209A1
|
|
A pharmaceutical formulation comprising inositol and selenium, preparation and use thereof
|
|
WO2013087755A1
|
|
Culture media for treating female gametes and embryos in medically assisted reproduction techniques
|
|
TW201320992A
|
|
Pharmaceutical composition comprising myo-inositol and d-chiro-inositol
|
|
WO2013050472A1
|
|
Diagnostic test comprising inositol for the assessment of the fertilising ability of human spermatozoa
|
|
WO2012175659A1
|
|
N-acetyl cysteine and composition thereof for use in the treatment of vaginal pathologies
|
|
HUE027991T2
|
|
Antioxidant composition for the reduction of the causes of reduced male reproductive capacity
|
|
ITMI20110445A1
|
|
PHARMACEUTICAL FORMULATION INCLUDING INOSITOLO.
|
|
EP2253228A2
|
|
Composition for controlling and improving female and male gametogenesis
|
|
WO2008155651A2
|
|
Inositol for induction of ovulation
|
